Page 189 - Harm Reduction News Today

BLOOMINGTON - The City of Bloomington Bloomington Arts Commission (BAC) is pleased to announce the recipients of its 2023 Arts Project Grant Cycle. Arts Project Grants are meant to help offset costs incurred by local artists and arts groups facilitating public-facing art projects. The Commission ...

/PRNewswire/ -- Today, the U.S. Food and Drug Administration approved RiVive, 3 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC),...

DOH Report Identifies Opportunities to Eliminate Hepatitis C Among Vulnerable Communities

The Food and Drug Administration on Friday approved the first version of over-the-counter (OTC) naloxone from a nonprofit company, a move that could bring cheap and even free doses of the opioid overdose drug to Americans who need it most. RiVive, made by Harm Reduction Therapeutics, is the second over-the-counter naloxone product approved by FDA…

The U.S. Food and Drug Administration on Friday approved a second over-the-counter naloxone nasal spray as "a powerful tool" to treat opioid overdoses.

The U.S. Food and Drug Administration approved the second naloxone nasal spray product available without a prescription.

The U.S. Food and Drug Administration on Friday approved a second over-the-counter naloxone nasal spray as "a powerful tool" to treat opioid overdoses.

Opioid-deaths in Timmins down from 40 to 22 in supervised consumption site’s first year of operations

This new data comes as part of the department's 2022 annual report. It began releasing these reports in 2020 in transparency efforts.

The Yakima Health District will start distributing a small portion of its recently purchased stock of the opioid overdose-reversing drug, Narcan, to select businesses in the county.